Predicting Adverse Outcomes in Women with Severe Pre-eclampsia

Seminars in Perinatology

Volumn 33, Issue 3, 2009, Pages 152-157

  von Dadelszen, Peter ^a,b   Menzies, Jennifer M ^a,b   Payne, Beth ^a,b   Magee, Laura A ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

outcome prediction; patient safety; pre eclampsia

Indexed keywords

MAGNESIUM SULFATE;

CLINICAL DECISION MAKING; CLINICAL TRIAL; DELIVERY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FETUS LUNG MATURATION; FETUS RISK; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; HYPERTENSION; LABOR INDUCTION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEDICAL RESEARCH; NEWBORN MORBIDITY; NEWBORN MORTALITY; PATIENT SAFETY; PRACTICE GUIDELINE; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK ASSESSMENT; RISK REDUCTION; STANDARDIZATION; STILLBIRTH;

COHORT STUDIES; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 65649096597     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2009.02.009     Document Type: Review

References (30)

1. Magee L.A., Ornstein M.P., and von Dadelszen P. Fortnightly review: Management of hypertension in pregnancy. BMJ 318 (1999) 1332-1336
2. Altman D., Carroli G., Duley L., et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate?. The magpie trial: A randomised placebo-controlled trial. Lancet 359 (2002) 1877-1890
3. Magee L.A., Helewa M.E., Moutquin J.M., et al. SOGC guidelines: Diagnosis, evaluation and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 30 suppl 3 (2008) S1-S48
4. Helewa M.E., Burrows R.F., Smith J., et al. Report of the Canadian Hypertension Society Consensus Conference. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 157 (1997) 715-725
5. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
6. Brown M.A., Hague W.M., Higgins J., et al. The detection, investigation and management of hypertension in pregnancy: Full consensus statement. Aust NZ J Obstet Gynaecol 40 (2000) 139-155
7. Caetano M., Ornstein M.P., von Dadelszen P., et al. A survey of Canadian practitioners regarding diagnosis and evaluation of the hypertensive disorders of pregnancy. Hypertens Pregnancy 23 (2004) 197-209
8. Magee L.A., von Dadelszen P., Bohun C.M., et al. Serious perinatal complications of non-proteinuric hypertension: An international, multicenter, retrospective cohort study. J Obstet Gynaecol Can 25 (2003) 372-382
9. Magee L.A., von Dadelszen P., Chan S., et al. The control of hypertension in pregnancy study pilot trial. Br J Obstet Gynaecol 114 (2007) e13-770, e20
10. Douglas K.A., and Redman C.W. Eclampsia in the United Kingdom. BMJ 309 (1994) 1395-1400
11. MacKay A.P., Berg C.J., and Atrash H.K. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 97 (2001) 533-538
12. von Dadelszen P., Magee L.A., Lee S.K., et al. Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: A therapeutic opportunity?. Crit Care Med 30 (2002) 1883-1892
13. Magee L.A., Yong P.J., Espinosa V., et al. Expectant management of pre-eclampsia remote from term: A structured systematic review. Hypertens Pregnancy (2009) Mar 25:1-36 (Epub ahead of print)
14. Caetano M., Ornstein M.P., von Dadelszen P., et al. A survey of Canadian practitioners regarding the management of the hypertensive disorders of pregnancy. Hypertens Pregnancy 23 (2004) 61-74
15. Koopmans C., van den Berg P., Mol B.W., et al. Pregnancy-induced hypertension and preeclampsia after 36 weeks: Induction of labour versus expectant monitoring. The HYPITAT trial. Hypertens Pregnancy 27 (2008) 421
16. Brown M.A., Lindheimer M.D., de Swiet M., et al. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20 (2001) IX-XIV
17. Menzies J., Magee L.A., Li J., et al. The Canadian Hypertension Society and National High Blood Pressure Education Program criteria for "severe" pre-eclampsia do not uniformly predict adverse outcomes. Hypertens Pregnancy 26 (2007) 447-462
18. Menzies J., Magee L.A., Li J., et al. Instituting surveillance guidelines and adverse outcomes in preeclampsia: A single site study. Obstet Gynecol 110 (2006) 121-127
19. von Dadelszen P., Magee L.A., Devarakonda R.M., et al. The prediction of adverse maternal outcomes in preeclampsia. J Obstet Gynaecol Can 26 (2004) 871-879
20. Martin Jr. J.N., May W.L., Magann E.F., et al. Early risk assessment of severe preeclampsia: Admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 180 (1999) 1407-1414
21. Lee S.K., Lee D.S., Andrews W.L., et al. Higher mortality rates among inborn infants admitted to neonatal intensive care units at night. J Pediatr 143 (2003) 592-597
22. von Dadelszen P, Barker S, Dale S, et al: Hypertens Pregnancy 11, 2006. Vancouver, BC, Reproductive Care Program. BCRCP Obstetric Guidelines
23. von Dadelszen P., Sawchuck D., McMaster R., et al. Active management of guidelines: Assessing the implementation of regional guidelines for the diagnosis and management of the hypertensive disorders of pregnancy. FIGO (2009) [Abstract]
24. Menzies J., von Dadelszen P., and PIERS Group. The PIERS (pre-eclampsia integrated estimate of risk) models: Univariable and cluster analyses. Hypertens Pregnancy 27 (2008) 620
25. von Dadelszen P., Menzies J., and PIERS Group. The PIERS (pre-eclampsia integrated Stimate of risk) models: Full-PIERS. Hypertens Pregnancy 27 (2008) 466
26. von Dadelszen P., Menzies J., and PIERS Group. The PIERS (pre-eclampsia integrated estimate of risk) models: Mini-PIERS. Hypertens Pregnancy 27 (2008) 621
27. Payne B., von Dadelszen P., and PIERS group. The WILL (when is intact livebirth likely) model: Using PIERS data to pilot a fetal prediction model. Hypertens Pregnancy 27 (2008) 623
28. Alfirevic Z., and Neilson J.P. The current status of Doppler sonography in obstetrics. Curr Opin Obstet Gynecol 8 (1996) 114-118
29. Nabhan AF, Abdelmoula YA: Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database Syst Rev Jul 16: CD006593
30. Serra V., Moulden M., Bellver J., et al. The value of the short-term fetal heart rate variation for timing the delivery of growth-retarded fetuses. BLDG 115 (2008) 1101-1107